Automating Analysis of Large-Scale Data for Flow Cytometry Screening
Application of NGS for Biosafety Assessment of Biologics
Sartorius Accelerates Development Processes by a Factor of 3
Digitalization Fuels Innovation in Vaccine Process Development
Pfizer Builds on the Genedata Biopharma E2E Workflow Platform
Deep Sequencing of Nanobody Libraries
Immatics Digitalizes CGT Discovery with Genedata Biologics
Streamlining NGS-Based Workflows in Cell Line Development
MorphoSys Advances Antibody R&D with Biologics
Inspiring Scientific Innovation through Data Federation
Introduction Video - Genedata Biologics for Biopharma Discovery
Accelerate CLD Using Data Management, Modeling, and Analytics
From Blueprint to Formulation: RNA Research with Genedata Biologics
NGS-Based Assays for CGT Development
Marie-Ange Kouassi February 14, 2024
Unlocking Opportunities in ATMP Development with NGS
Discrimination of Pancreato-Biliary Cancer by Non-Invasive Liquid Biopsy
Molecular Cancer February 7, 2024
Harnessing the Power of Data in the Fight Against Cancer
Genedata February 4, 2024
NGS Revolution for Establishing CQAs of CGT Products
Marie-Ange Kouassi January 30, 2024
Automating Data Analysis in Gene Expression Screens
Ensuring Safe Cell Therapy Products with a GMP-Compliant Platform
Data Processing Automation Powered by Genedata Screener
Inhibiting KIF18A in Chromosomally Unstable Cancer
Nature Cancer January 17, 2024
Characterization of disulfide bridges pattern
Rapid Commun. Mass Spectrom. January 17, 2024
Automating NGS Workflows to Accelerate Crop Protection Programs
Streamlining Data and Global Collaboration in Breeding Programs
Genedata Selector for Precise Genome Editing
Genedata Selector
CRISPR-Based Targeted Engineering
Genedata Profiler 16.3 Highlights Video
NGS-Based Biologics Quality Control Testing
Unlocking CQA Measurement of Gene Therapy Products with NGS
Advancing Early Cancer Immunotherapy Trials
Accelerating CGT Product Development via NGS
Urszula Cendrowska November 15, 2023
Genedata Selector Open Forum 8: Introduction by Astellas
GMP-Compliant Viral Risk Assessment of Live Vaccines
NGS as a Multi-Attribute Method for Cell Therapy Production QC
Automated Patchwise Sampling During Deep Learning-Based Image Analysis
Revolutionizing CSV for NGS-Based Assays
Improving Efficiency in Discovery and Development of Bispecifics and ADCs
Designing and Screening Complex Proteins with Novel Capabilities at Industrial Scale
Automated & Unbiased New Peak Detection for MAM Implementations
